Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
Thursday, January 22, 2026 1 min read
Key Takeaway: Charles River Laboratories will announce its fourth-quarter and full-year 2025 financial results on February 18th, along with guidance for 2026. A conference call is set for the same day at 8:30 a.m. ET, allowing investors to engage directly with the company's leadership. This event reflects the company's commitment to transparency and investor relations.
Price reaction · baseline $226.77 (2026-01-21 close) · hit pre-market · clean, no other CRL news in the window
Conference call provides a platform for investor engagement.
2026 guidance suggests future growth potential.
Full Press Release Details
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2025 financial results and provide 2026 guidance on Wednesday, February 18th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 18th, at 8:30 a.m. ET.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website atir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visitwww.criver.com.